Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies

被引:211
作者
Fu, YR
Yang, SC
Jeong, SH
Kimura, S
Park, K
机构
[1] Purdue Univ, Sch Pharm, Dept Pharmaceut, W Lafayette, IN 47907 USA
[2] Purdue Univ, Sch Pharm, Dept Biomed Engn, W Lafayette, IN 47907 USA
来源
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 2004年 / 21卷 / 06期
关键词
fast dissolving; fast disintegrating; fast melting; taste masking; disintegration; time; clinical studies;
D O I
10.1615/CritRevTherDrugCarrierSyst.v21.i6.10
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Fast disintegrating tablets (FDTs) have received ever-increasing demand during the last decade, and the field has become a rapidly growing area in the pharmaceutical industry. Upon introduction into the mouth, these tablets dissolve or disintegrate in the mouth in the absence of additional water for easy administration of active pharmaceutical ingredients. The popularity and usefulness of the formulation resulted in development of several FDT technologies. This review describes various formulations and technologies developed to achieve fast dissolution/dispersion of tablets in the oral cavity. In particular, this review describes in detail FDT technologies based on lyophilization, molding, sublimation, and compaction, as well as approaches to enhancing the FDT properties, such as spray-drying, moisture treatment, sintering, and use of sugar-based disintegrants. In addition, taste-masking technologies, experimental measurements of disintegration times, and clinical studies are also discussed.
引用
收藏
页码:433 / 475
页数:43
相关论文
共 110 条
[1]
The preparation of orally disintegrating tablets using a hydrophilic waxy binder [J].
Abdelbary, G ;
Prinderre, P ;
Eouani, C ;
Joachim, J ;
Reynier, JP ;
Piccerelle, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 278 (02) :423-433
[2]
ALLEN LV, 2001, Patent No. 6207199
[3]
AMBORN J, 2001, Patent No. 6311462
[4]
[Anonymous], US PHARM
[5]
Lansoprazole fast disintegrating tablet: A new formulation for an established proton pump inhibitor [J].
Baldi, F ;
Malfertheiner, P .
DIGESTION, 2003, 67 (1-2) :1-5
[6]
Mirtazapine orally disintegrating tablet versus sertraline:: A prospective onset of action study [J].
Behnke, K ;
Sogaard, J ;
Martin, S ;
Bäuml, J ;
Ravindran, AV ;
Ågren, H ;
Vester-Blokland, ED .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (04) :358-364
[7]
BETTMAN MJ, 1998, Patent No. 5709886
[8]
Bi YX, 1996, CHEM PHARM BULL, V44, P2121
[9]
Rapidly disintegrating tablets prepared by the wet compression method: Mechanism and optimization [J].
Bi, YX ;
Yonezawa, Y ;
Sunada, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (10) :1004-1010
[10]
BONADEO D, 1998, Patent No. 6149938